Back

Phenome-wide causal proteomics enhance systemic lupus erythematosus flare prediction: A study in Asian populations

Chen, L.; DENG, O.; Fang, T.; Chen, M.; Zhang, X.; Cong, R.; Lu, D.; Zhang, R.; Jin, Q.; Wang, X.

2024-11-18 health informatics
10.1101/2024.11.17.24317460
Show abstract

ObjectiveSystemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares. This study aimed to develop a novel proteomics-based risk prediction model specifically for Asian SLE populations to enhance personalized disease management and early intervention. MethodsA longitudinal cohort study was conducted over 48 weeks, including 139 SLE patients monitored every 12 weeks. Patients were classified into flare (n = 53) and non-flare (n = 86) groups. Baseline plasma samples underwent data-independent acquisition (DIA) proteomics analysis, and phenome-wide Mendelian randomization (PheWAS) was performed to evaluate causal relationships between proteins and clinical predictors. Logistic regression (LR) and random forest (RF) models were used to integrate proteomic and clinical data for flare risk prediction. ResultsFive proteins (SAA1, B4GALT5, GIT2, NAA15, and RPIA) were significantly associated with SLE Disease Activity Index-2K (SLEDAI-2K) scores and 1-year flare risk, implicating key pathways such as B-cell receptor signaling and platelet degranulation. SAA1 demonstrated causal effects on flare-related clinical markers, including hemoglobin and red blood cell counts. A combined model integrating clinical and proteomic data achieved the highest predictive accuracy (AUC = 0.769), surpassing individual models. SAA1 was highlighted as a priority biomarker for rapid flare discrimination. ConclusionThe integration of proteomic and clinical data significantly improves flare prediction in Asian SLE patients. The identification of key proteins and their causal relationships with flare-related clinical markers provides valuable insights for proactive SLE management and personalized therapeutic approaches. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=191 SRC="FIGDIR/small/24317460v1_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@1137aceorg.highwire.dtl.DTLVardef@1e3773eorg.highwire.dtl.DTLVardef@a9af65org.highwire.dtl.DTLVardef@3a186e_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
based on 140 papers
Top 0.1%
16.2%
2
JCI Insight
based on 63 papers
Top 0.5%
9.2%
3
Annals of the Rheumatic Diseases
based on 23 papers
Top 0.5%
4.7%
4
European Respiratory Journal
based on 44 papers
Top 1%
3.1%
5
BMC Medical Genomics
based on 12 papers
Top 0.1%
3.1%
6
Journal of Personalized Medicine
based on 17 papers
Top 0.2%
3.0%
7
Cell Reports Medicine
based on 49 papers
Top 2%
2.6%
8
Viruses
based on 79 papers
Top 2%
2.4%
9
iScience
based on 74 papers
Top 2%
1.9%
10
PLOS ONE
based on 1737 papers
Top 87%
1.9%
11
GeroScience
based on 22 papers
Top 0.9%
1.9%
50% of probability mass above
12
Scientific Reports
based on 701 papers
Top 68%
1.9%
13
Critical Care
based on 14 papers
Top 1.0%
1.7%
14
eBioMedicine
based on 82 papers
Top 3%
1.4%
15
Arthritis & Rheumatology
based on 21 papers
Top 0.9%
1.4%
16
Biomedicines
based on 21 papers
Top 2%
1.4%
17
Nature Communications
based on 483 papers
Top 33%
1.4%
18
Frontiers in Medicine
based on 99 papers
Top 15%
1.3%
19
Communications Medicine
based on 63 papers
Top 3%
0.8%
20
Science Translational Medicine
based on 40 papers
Top 4%
0.8%
21
Frontiers in Microbiology
based on 36 papers
Top 3%
0.8%
22
Journal of Biomedical Informatics
based on 37 papers
Top 5%
0.8%
23
Advanced Science
based on 12 papers
Top 2%
0.7%
24
JAMIA Open
based on 35 papers
Top 6%
0.7%
25
Transfusion
based on 14 papers
Top 0.8%
0.7%
26
Journal of the American Medical Informatics Association
based on 53 papers
Top 7%
0.7%
27
Clinical and Translational Science
based on 14 papers
Top 2%
0.7%
28
Journal of Medical Virology
based on 95 papers
Top 10%
0.7%